Market Cap (In NOK)
48.2 Million
Revenue (In NOK)
33.75 Million
Net Income (In NOK)
-45.51 Million
Avg. Volume
9165.00
- Currency
- NOK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.65-16.8
- PE
- -
- EPS
- -
- Beta Value
- 1.141
- ISIN
- NO0010859580
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Christer L. Valderhaug
- Employee Count
- -
- Website
- https://www.arctic-bioscience.com
- Ipo Date
- 2021-02-24
- Details
- Arctic Bioscience AS, a biotechnology company, develops and commercializes pharmaceutical and nutraceutical products. Its development stage product candidate is HRO350, a novel oral treatment for mild-to-moderate psoriasis. The company sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.
More Stocks
-
6390Kato Works Co.,Ltd.
6390
-
GRGCFGeorgia Capital PLC
GRGCF
-
PEA
-
VET
-
601808
-
000590CS Holdings Co., Ltd.
000590
-
GUJCRED
-
ECN